Dutch/Belgian Euronext- and Nasdaq-listed argenx, a global immunology innovation company, is to acquire Nasdaq-listed Forte Biosciences, a clinical-stage biopharmaceutical company, for US$77 per share in cash, representing a total equity value of approximately US$2.2bn - a premium of approximately 86% to Forte Biosciences’ VWAP since reporting positive Phase 1b...
Euronext-listed Dassault Systèmes, a France-based multinational software corporation, has agreed to acquire US-based ArisGlobal, an AI-native enterprise compliance platform for the Life Sciences industry, for approximately US$1.8bn in cash at closing and up to US$200m in additional consideration linked to multi-year AI-related revenue milestones.
Founded in 1989, ArisGlobal’s AI-native enterprise compliance platform serves over 200 customers, including half of the Top 50 global biopharma companies as well as biotech, medtech, CROs and global health authorities. Its regulated core platform is deeply embedded within mission-critical operations and processes more than 12...